William Blair & Company
BIO icon

William Blair & Company’s Bio-Rad Laboratories Class A BIO Stock Holding History

William Blair & Company’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-429
Closed -$324K – 1914
2021
Q4 		$324K Buy
429
+79
+23% +$59.1K ﹤0.01% 1390
2021
Q3 		$261K Sell
350
-12
-3% -$8.99K ﹤0.01% 1381
2021
Q2 		$233K Buy
362
+4
+1% +$2.43K ﹤0.01% 1448
2021
Q1 		$204K Sell
358
-9
-2% -$5.33K ﹤0.01% 1476
2020
Q4 		$214K Buy
+367
New +$209K ﹤0.01% 1404

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

William Blair & Company's BIO Position: Q1 2022 in Review

William Blair & Company sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2022, closing a stake of 429 shares — an estimated $324K sold.

William Blair & Company first reported a position in BIO in Q4 2020 and held it in 5 quarters. The position peaked at $324K in Q4 2021. 514 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

  • William Blair & Company reported no remaining Bio-Rad Laboratories Class A position as of Q1 2022 after selling out during the quarter.
  • William Blair & Company sold 429 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $324K.
  • William Blair & Company first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and held it in 5 quarters.
  • William Blair & Company's Bio-Rad Laboratories Class A position peaked at $324K in Q4 2021.
  • 514 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on William Blair & Company's 13F filing for Q1 2022, filed 13 May 2022.